Literature DB >> 9018061

Regulated expression vectors demonstrate cell-type-specific sensitivity to human immunodeficiency virus type 1 Nef-induced cytostasis.

S J Cooke1, K Coates, C H Barton, T E Biggs, S J Barrett, A Cochrane, K Oliver, J A McKeating, M P Harris, D A Mann.   

Abstract

The nef gene product of both human and simian immunodeficiency viruses is critically important for virus replication and disease progression in vivo. However, the precise biological function of Nef remains poorly characterized in vitro, with previous reports suggesting that Nef might be either cytotoxic or cytostatic. As a result of difficulties encountered by several groups in establishing cell lines constitutively expressing Nef, we have developed two inducible systems resulting in stable Nef expression in various mammalian cell lines. Tetracycline-regulated Nef expression was achieved in HeLa cells but could not be established in human T cell lines. Jurkat E6-1 T cell and RAW264.7 murine macrophage cell lines expressing a regulated nef gene were generated using a system in which Nef expression was controlled by a mutated version of the heavy metal-inducible human metallothionein IIA promoter. Induction of high levels of Nef expression in HeLa-Nef and Jurkat-Nef cells resulted in a moderate (2-fold) and a dramatic (10-fold) retardation of cell growth respectively, supporting the contention that Nef may be a cytotoxic or cytostatic factor. This property was also observed at low basal levels of Nef expression in RAW264.7-Nef macrophage clones (5-fold reduction in growth) and was associated with an altered morphological phenotype suggesting that different cell types may be more susceptible to the cytostatic activity of Nef. The regulated Nef-expression systems provide tools for investigating the molecular basis of Nef function, including Nef-mediated cytopathogenicity, CD4 down-regulation and enhancement of virus infectivity.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9018061     DOI: 10.1099/0022-1317-78-2-381

Source DB:  PubMed          Journal:  J Gen Virol        ISSN: 0022-1317            Impact factor:   3.891


  10 in total

1.  Myosin-X is essential to the intercellular spread of HIV-1 Nef through tunneling nanotubes.

Authors:  Jaime Uhl; Shivalee Gujarathi; Abdul A Waheed; Ana Gordon; Eric O Freed; Karine Gousset
Journal:  J Cell Commun Signal       Date:  2018-11-15       Impact factor: 5.782

2.  High level expression of Nramp1G169 in RAW264.7 cell transfectants: analysis of intracellular iron transport.

Authors:  P G Atkinson; C H Barton
Journal:  Immunology       Date:  1999-04       Impact factor: 7.397

3.  CD4+ T cells from CD4C/HIVNef transgenic mice show enhanced activation in vivo with impaired proliferation in vitro but are dispensable for the development of a severe AIDS-like organ disease.

Authors:  Xiaoduan Weng; Elena Priceputu; Pavel Chrobak; Johanne Poudrier; Denis G Kay; Zaher Hanna; Tak W Mak; Paul Jolicoeur
Journal:  J Virol       Date:  2004-05       Impact factor: 5.103

4.  Virion incorporation of human immunodeficiency virus type 1 Nef is mediated by a bipartite membrane-targeting signal: analysis of its role in enhancement of viral infectivity.

Authors:  R Welker; M Harris; B Cardel; H G Kräusslich
Journal:  J Virol       Date:  1998-11       Impact factor: 5.103

5.  Regulated overexpression of the survival factor bcl-2 in CHO cells increases viable cell density in batch culture and decreases DNA release in extended fixed-bed cultivation.

Authors:  M Fussenegger; D Fassnacht; R Schwartz; J A Zanghi; M Graf; J E Bailey; R Pörtner
Journal:  Cytotechnology       Date:  2000-01       Impact factor: 2.058

6.  HIV-1 Nef mobilizes lipid rafts in macrophages through a pathway that competes with ABCA1-dependent cholesterol efflux.

Authors:  Huanhuan L Cui; Angela Grant; Nigora Mukhamedova; Tatiana Pushkarsky; Lucas Jennelle; Larisa Dubrovsky; Katharina Gaus; Michael L Fitzgerald; Dmitri Sviridov; Michael Bukrinsky
Journal:  J Lipid Res       Date:  2012-01-19       Impact factor: 5.922

7.  Expression, intracellular targeting and purification of HIV Nef variants in tobacco cells.

Authors:  Carla Marusic; James Nuttall; Giampaolo Buriani; Chiara Lico; Raffaele Lombardi; Selene Baschieri; Eugenio Benvenuto; Lorenzo Frigerio
Journal:  BMC Biotechnol       Date:  2007-02-26       Impact factor: 2.563

8.  Cytotoxic T lymphocyte epitopes of HIV-1 Nef: Generation of multiple definitive major histocompatibility complex class I ligands by proteasomes.

Authors:  M Lucchiari-Hartz; P M van Endert; G Lauvau; R Maier; A Meyerhans; D Mann; K Eichmann; G Niedermann
Journal:  J Exp Med       Date:  2000-01-17       Impact factor: 14.307

Review 9.  Plant-based strategies aimed at expressing HIV antigens and neutralizing antibodies at high levels. Nef as a case study.

Authors:  Carla Marusic; Alessandro Vitale; Emanuela Pedrazzini; Marcello Donini; Lorenzo Frigerio; Ralph Bock; Philip J Dix; Matthew S McCabe; Michele Bellucci; Eugenio Benvenuto
Journal:  Transgenic Res       Date:  2009-01-25       Impact factor: 2.788

10.  Alterations in intracellular potassium concentration by HIV-1 and SIV Nef.

Authors:  Bongkun Choi; Cesar D Fermin; Alla M Comardelle; Allyson M Haislip; Thomas G Voss; Robert F Garry
Journal:  Virol J       Date:  2008-05-19       Impact factor: 4.099

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.